Oracle Enables Automation of Drug Supply Management Across Vendors and Studies to Help Speed and Simplify Clinical Trials

Rhea-AI Summary

Oracle has announced significant enhancements to its Randomization and Trial Supply Management (RTSM) solution, introducing new drug pooling and interoperability features that enable pharmaceutical companies to manage drug inventory across multiple clinical trials simultaneously. The system now supports integrated supply management with major vendors including SAP, Almac, Fisher Clinical Services, Catalent, and PMD. Built on Oracle Cloud Infrastructure, RTSM provides end-to-end automation for drug supply management and includes built-in analytics for monitoring inventory levels, shipment status, and drug usage across trial portfolios. These improvements aim to reduce inefficiencies, minimize waste, and accelerate trial execution timelines while ensuring the right drug reaches the right site at the right time.

Positive

• New drug pooling feature enables simultaneous management of drug inventory across multiple clinical trials
• Integration with major vendors (SAP, Almac, Fisher Clinical Services, Catalent, PMD) streamlines supply management
• Built-in analytics provide centralized monitoring of inventory levels and shipment status
• End-to-end automation capabilities help reduce inefficiencies and waste in clinical trials

Negative

• None.

Insights

Healthcare Technology Analyst

Oracle's RTSM enhancements enable cross-trial drug management and multi-vendor integration, potentially accelerating clinical trials and strengthening Oracle's healthcare market position.

Oracle has introduced significant interoperability advancements to its Randomization and Trial Supply Management (RTSM) solution that directly address critical bottlenecks in clinical trial operations. The new drug pooling capabilities represent a fundamental shift in how pharmaceutical companies can manage investigational products across multiple trials simultaneously, potentially reducing drug waste and accelerating study timelines.

The integration with major supply chain vendors including SAP, Almac, Fisher Clinical Services, Catalent, and PMD is particularly noteworthy. This vendor-agnostic approach addresses the fragmentation that has historically plagued clinical trial logistics, where studies often operate in technological silos. By enabling seamless communication across disparate systems, Oracle is positioning itself as an interoperability leader in an industry that desperately needs standardization.

The built-in analytics for centralized inventory tracking across trial portfolios will likely appeal to large pharmaceutical companies managing complex development programs across multiple therapeutic areas. This cross-trial visibility has been a persistent challenge in clinical operations.

These enhancements align with Oracle's broader strategy to unify its life sciences applications with clinical systems following its $28 billion Cerner acquisition. The emphasis on creating an "intelligent, continuously learning ecosystem" signals Oracle's push toward more AI-driven clinical trial processes, potentially strengthening its competitive position against specialized clinical trial technology providers and other large healthcare IT vendors in the $10+ billion clinical trials software market.

New vendor-agnostic interoperability advancements in Oracle Randomization and Trial Supply Management enable drug pooling and seamless supply management automation across multiple trials

AUSTIN, Texas, June 4, 2025 /PRNewswire/ -- New interoperability advancements in Oracle's enterprise-grade Randomization and Trial Supply Management (RTSM) solution are helping simplify and optimize drug supply management across complex clinical trials and multiple therapeutic areas. New drug pooling and interoperability enhancements enable sponsors and CROs to control drug inventory across various clinical trials simultaneously using the same investigational product. This aids in reducing inefficiencies and waste, and accelerating trial execution timelines. In addition, Oracle RTSM now supports fully integrated supply management with SAP, Almac, Fisher Clinical Services, Catalent, and PMD—to help the right drug reach the right site at the right time, regardless of the study's technology platform.

Built on the security, performance and scalability of Oracle Cloud Infrastructure (OCI), RTSM delivers end-to-end automation for drug supply ordering, tracking, and allocation across RTSM systems and clinical sites. This supports a growing demand for multi-vendor strategies and cross-trial flexibility. RTSM also offers built in analytics to provide centralized inventory levels, shipment statuses, and drug usage across the user's trial portfolio and multiple workflow streams. RTSM is part of Oracle's broad portfolio of integrated clinical trial applications.

These changes reflect Oracle's strategy of prioritizing interoperability, connectivity, AI-driven automation, and agentic workflows. This approach underpins Oracle's vision to unify its life sciences and clinical applications, such as electronic health records, to create an intelligent, continuously learning ecosystem that can help accelerate innovation, reduce costs, and improve care. In this environment, hospitals will be able to initiate trials quickly, identify eligible patients at the point of care, and continuously capture real-world data—making research more connected, intelligent, and patient-centric.

"Our latest enhancements reflect Oracle's continued commitment to interoperability and to delivering an open and connected ecosystem—empowering sponsors to accelerate innovation, reduce complexity, and drive better outcomes for patients," said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. "Today's clinical trials often span multiple studies, systems, and vendors. By enabling drug pooling and supply management automation across platforms, we're helping organizations manage inventory more efficiently, optimize resources, and move promising therapies forward faster."

For more information about Oracle's integrated clinical trial portfolio and services, visit oracle.com/life.

About Oracle Life Sciences
Oracle Life Sciences is a leader in cloud technology, pharmaceutical research, and consulting, trusted globally by professionals in both large and emerging companies engaged in clinical research and pharmacovigilance, throughout the therapeutic development lifecycle, including pre- and post-drug launch activities. With more than 20 years of experience, Oracle Life Sciences is committed to supporting clinical development and leveraging real-world evidence to deliver innovation and accelerate advancements—empowering the Life Sciences industry to improve patient outcomes. Learn more at www.oracle.com/lifesciences.

About Oracle
Oracle offers integrated suites of applications plus secure, autonomous infrastructure in the Oracle Cloud. For more information about Oracle (NYSE: ORCL), please visit us at www.oracle.com.

Trademarks
Oracle, Java, MySQL and NetSuite are registered trademarks of Oracle Corporation. NetSuite was the first cloud company—ushering in the new era of cloud computing.

View original content to download multimedia:https://www.prnewswire.com/news-releases/oracle-enables-automation-of-drug-supply-management-across-vendors-and-studies-to-help-speed-and-simplify-clinical-trials-302472579.html

SOURCE Oracle

FAQ

What are the key features of Oracle's enhanced RTSM solution?

Oracle's enhanced RTSM solution includes drug pooling capabilities, multi-vendor integration, end-to-end automation for drug supply management, and built-in analytics for inventory monitoring across trial portfolios.

Which vendors are now integrated with Oracle's RTSM system?

Oracle's RTSM system is now integrated with SAP, Almac, Fisher Clinical Services, Catalent, and PMD for supply management.

How does Oracle RTSM's drug pooling feature benefit clinical trials?

The drug pooling feature allows sponsors to manage drug inventory across multiple clinical trials simultaneously, reducing inefficiencies, minimizing waste, and accelerating trial execution timelines.

What analytics capabilities does Oracle RTSM offer?

Oracle RTSM provides built-in analytics for monitoring centralized inventory levels, shipment statuses, and drug usage across trial portfolios and multiple workflow streams.

How does Oracle RTSM improve clinical trial efficiency?

Oracle RTSM improves efficiency through end-to-end automation, vendor-agnostic interoperability, drug pooling capabilities, and seamless supply management automation across multiple trials.